Collegium Pharmaceutical Inc.
COLL | NASDAQ
$23.15
+$0.11 (+0.48%)
Sep 22, 2026, 12:52 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 808.21M | 796.33M | 780.57M | 757.07M | 707.01M | 664.28M | 631.45M | 599.25M | 576.65M | 566.92M | 566.77M | 546.64M | 536.95M | 524.95M | 463.93M | 361.68M | 313.51M | 272.9M | 276.87M | 325.78M | 326.11M | 321.23M |
Cost of Revenue | 323.12M | 313.15M | 317.31M | 323.9M | 306.22M | 281.07M | 254.11M | 225.56M | 219.45M | 226.7M | 240.6M | 265.31M | 277.09M | 286.56M | 254.45M | 203.31M | 167.87M | 129.38M | 126.25M | 129.54M | 127.79M | 124.78M |
Gross Profit | 485.09M | 483.18M | 463.26M | 433.17M | 400.79M | 383.21M | 377.34M | 373.69M | 357.2M | 340.22M | 326.17M | 281.33M | 259.86M | 238.39M | 209.49M | 158.37M | 145.64M | 143.52M | 150.62M | 196.24M | 198.32M | 196.45M |
Operating Income | 158.51M | 189.91M | 179.64M | 158.52M | 129.74M | 142.11M | 169.9M | 193.47M | 203.65M | 191.81M | 166.96M | 117.03M | 92.48M | 67.96M | 33.32M | -12.56M | -18.88M | -13.58M | 17.63M | 66.75M | 72.22M | 72.36M |
Interest Income | 12.68M | 12.77M | 11.29M | 9.54M | 9.7M | 11.71M | 13.98M | 16.47M | 17.73M | 17.36M | 15.62M | 12.34M | 7.81M | 3.79M | 1.05M | 23K | 15K | 13K | 12K | 12K | 12K | 23K |
Pretax Income | 77.68M | 108.24M | 92.62M | 80.85M | 53M | 65.07M | 98.57M | 128.01M | 141.21M | 129.91M | 75.73M | 21.23M | -6.12M | -30.56M | -28.85M | -59.93M | -52.33M | -34.69M | -3.37M | 42.76M | 45.29M | 42.61M |
Net Income | 47.92M | 74.95M | 62.87M | 58.44M | 36.27M | 43.89M | 69.19M | 88.59M | 99.89M | 93.29M | 48.16M | 9.02M | -11.16M | -29.36M | -25M | -42.84M | -35.25M | 42.79M | 71.52M | 103.51M | 106.75M | 41.96M |
Selling & General & Admin | 239.79M | 206.83M | 283.25M | 278.7M | 275.11M | 244.8M | 210.36M | 180.21M | 153.56M | 148.42M | 159.21M | 164.3M | 167.37M | 170.43M | 172.19M | 160.76M | 152.9M | 142.01M | 118.96M | 119.18M | 115.09M | 114.05M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.98M | 5.59M | 7.04M | 10.5M | 9.45M | 10.31M | 11.01M | 10.04M |
Other Expenses | 86.8M | 86.44M | 370K | -4.06M | -4.06M | -3.7M | -2.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 4.58M | 4.58M | 4.58M | 4.58M | n/a | n/a | n/a |
Operating Expenses | 326.58M | 293.27M | 283.62M | 274.64M | 271.05M | 241.1M | 207.45M | 180.21M | 153.56M | 148.42M | 159.21M | 164.3M | 167.37M | 170.43M | 176.17M | 170.93M | 164.52M | 157.09M | 132.99M | 129.5M | 126.1M | 124.08M |
Interest Expense | 161.94M | 162.89M | 167.81M | 85.67M | 82.3M | 77.43M | 73.97M | 70.6M | 72.98M | 79.25M | 83.34M | 84.63M | 82.91M | 78.81M | 63.21M | 47.4M | 33.46M | 21.12M | 21.01M | 23.99M | 26.94M | 29.78M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7.41M | 7.41M | 7.41M | 7.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -87.01M | -60.58M | -31.26M |
Cost & Expenses | 649.7M | 606.42M | 600.93M | 598.54M | 577.27M | 522.18M | 461.55M | 405.77M | 373.01M | 375.12M | 399.81M | 429.61M | 444.46M | 456.99M | 430.61M | 374.24M | 332.38M | 286.48M | 259.24M | 259.03M | 253.89M | 248.86M |
Income Tax Expense | 29.77M | 33.29M | 29.75M | 22.41M | 16.73M | 21.17M | 29.38M | 39.42M | 41.32M | 36.62M | 27.58M | 12.22M | 5.04M | -1.2M | -3.85M | -17.1M | -17.08M | -77.48M | -74.89M | -60.75M | -61.46M | 642K |
Shares Outstanding (Basic) | 32.46M | 32.09M | 31.71M | 31.57M | 31.81M | 31.79M | 32.08M | 32.26M | 32.43M | 32.33M | 32.3M | 33.74M | 34.62M | 34.32M | 33.58M | 34.06M | 34M | 33.51M | 34.11M | 35.37M | 35.3M | 34.95M |
Shares Outstanding (Diluted) | 32.46M | 40.07M | 39.7M | 39.44M | 39.08M | 32.84M | 40.11M | 40.16M | 40.38M | 41.44M | 41.28M | 42.06M | 42.85M | 34.32M | 33.58M | 34.57M | 34M | 33.67M | 34.12M | 36.26M | 41.29M | 41.16M |
EPS (Basic) | 1.53 | 2.37 | 2 | 1.85 | 1.18 | 1.40 | 2.18 | 2.78 | 3.06 | 2.84 | 1.47 | 0.27 | -0.33 | -0.86 | -0.74 | -1.26 | -1.04 | 1.17 | 2.01 | 2.94 | 3.04 | 1.21 |
EPS (Diluted) | 1.24 | 2.04 | 1.71 | 1.60 | 1.03 | 1.21 | 1.85 | 2.32 | 2.58 | 2.40 | 1.18 | 0.15 | -0.37 | -0.86 | -0.74 | -1.26 | -1.05 | 0.89 | 1.69 | 2.62 | 2.72 | 1.16 |
EBITDA | 586.57M | 609.91M | 599.85M | 392.72M | 346.73M | 332.78M | 341.7M | 346.72M | 357.66M | 355.42M | 308.07M | 262.5M | 234.28M | 205.91M | 173.49M | 100.7M | 73.67M | 57.76M | 86.57M | 135.54M | 140.76M | 140.68M |
EBIT | 239.62M | 271.12M | 260.43M | 166.53M | 135.3M | 142.49M | 172.54M | 198.61M | 214.19M | 209.16M | 159.07M | 105.87M | 76.79M | 48.25M | 34.37M | -12.54M | -18.86M | -13.57M | 17.64M | 66.76M | 72.24M | 72.39M |
Depreciation & Amortization | 346.94M | 338.79M | 339.41M | 226.19M | 211.43M | 190.29M | 169.16M | 148.11M | 143.47M | 146.25M | 149M | 156.64M | 157.48M | 157.66M | 139.12M | 113.24M | 92.53M | 71.33M | 68.93M | 68.79M | 68.53M | 68.3M |
Add to Watchlist
Select watchlists to add or remove COLL